Markets extended their rebound for a second consecutive session on Thursday, buoyed by supportive global cues and selective buying in heavy...

In the stock market, everything has to be seen in context. The most noticeable thing these past few days is that there is not much Gulf-rel...

In the April 2022-September 2024 bull market, every management appeared capable. Margins expanded, working capital looked manageable, capit...

What we are witnessing in the market these days is similar to scenarios that have played out in the past. There have been many points in th...

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

Over the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...

Markets ended flat on Thursday after a volatile session, with analysts maintaining a positive outlook and recommending a buy-on-dips strate...

Alembic Pharmaceuticals has received final approval from the US Food and Drug Administration for its generic methotrexate injection, used t...

What is evident in the last few trading sessions is how the street is treating Q4 earnings numbers. If a company delivers in terms of numbe...

Brimonidine Tartrate Ophthalmic Solution is an alpha-adrenergic receptor agonist indicated for the reduction of elevated intraocular pressu...

Alembic Pharmaceuticals, incorporated in the year 2010, is a Mid Cap company (having a market cap of Rs 10695.00 Crore) operating in Pharma...

“The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Apriso Extended-Release Capsules, 0.375 g, of ...

Alembic Pharma delivered a better than expected operational performance, led by better-than-industry growth in the Domestic Formulations (D...

Shares of Alembic Pharmaceuticals declined 10 per cent to Rs 822.60, its new 52-week low, on Tuesday.

Shares of Alembic Pharmaceuticals Ltd. traded 12.4 per cent up in trade at 11:57AM on Friday .

Alembic Pharmaceuticals is a midcap company, operating in pharmaceuticals and health care sector.

"APL and Orbicular will own 60 per cent and 40 per cent of the equity capital of Aleor when the transaction is completed," the Vadodara-bas...